MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

INTRODUCTION: The incidence of hepatotoxicity has never been reported for intensive induction chemotherapy regimens for young children with primary malignant CNS tumors. We report our comprehensive review of available data on patients enrolled on the Head Start II trial 1997-2003. METHODS: Retrospec...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Abu Arja, Mohammad H, Mehyar, Lubna S, Osorio, Diana S, Coven, Scott, Gardner, Sharon, Finlay, Jonathan L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012657/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.429
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia